Advancing Hair Loss Assessment in Alopecia Areata: The Mathematical Case for Centralized, Standardized Imaging

In a Phase 2 clinical trial for mild-to-moderate alopecia areata (AA), researchers compared centralised and local measurements of hair loss using the Severity of Alopecia Tool (SALT) score. Centralised measurements, conducted from standardised photographic images, showed greater consistency and smaller margins of error—50% lower than local ratings. Monte-Carlo simulations indicated that using centralised ratings could reduce the likelihood of statistically significant outcomes by at least 50% compared to local ratings. The study concludes that centralised rating is more appropriate during the Phase 2 learning stage of clinical development, as it provides a more accurate and consistent assessment of hair loss.